Jupiter Asset Management LTD Exact Sciences Corp Transaction History

Jupiter Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$56.27 - $73.77 $3.49 Million - $4.58 Million	62,078 Added 17.98%	407,417 $28.1 Million
Q4 2023 Feb 09, 2024	BUY	$59.06 - $75.72 $9.63 Million - $12.4 Million	163,117 Added 89.52%	345,339 $25.5 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $12 Million - $18 Million	182,222 New	182,222 $12.4 Million
Q1 2023 May 10, 2023	SELL	$47.19 - $70.77 $609,694 - $914,348	-12,920 Reduced 49.31%	13,282 $900,000
Q4 2022 Feb 10, 2023	BUY	$30.35 - $53.15 $164,952 - $288,870	5,435 Added 26.17%	26,202 $1.3 Million
Q2 2022 Aug 10, 2022	BUY	$35.61 - $76.23 $739,512 - $1.58 Million	20,767 New	20,767 $818,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.